Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

77 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Circulating TREM2 as a noninvasive diagnostic biomarker for NASH in patients with elevated liver stiffness.
Indira Chandran V, Wernberg CW, Lauridsen MM, Skytthe MK, Bendixen SM, Larsen FT, Hansen CD, Grønkjær LL, Siersbæk MS, Caterino TD, Detlefsen S, Møller HJ, Grøntved L, Ravnskjaer K, Moestrup SK, Thiele MS, Krag A, Graversen JH. Indira Chandran V, et al. Among authors: hansen cd. Hepatology. 2023 Feb 1;77(2):558-572. doi: 10.1002/hep.32620. Epub 2022 Jul 14. Hepatology. 2023. PMID: 35712786 Free PMC article.
Comprehensive lipidomics reveals phenotypic differences in hepatic lipid turnover in ALD and NAFLD during alcohol intoxication.
Israelsen M, Kim M, Suvitaival T, Madsen BS, Hansen CD, Torp N, Trost K, Thiele M, Hansen T, Legido-Quigley C, Krag A; MicrobLiver Consortium. Israelsen M, et al. Among authors: hansen cd, hansen t. JHEP Rep. 2021 Jun 29;3(5):100325. doi: 10.1016/j.jhepr.2021.100325. eCollection 2021 Oct. JHEP Rep. 2021. PMID: 34401690 Free PMC article.
Binge drinking induces an acute burst of markers of hepatic fibrogenesis (PRO-C3).
Torp N, Israelsen M, Nielsen MJ, Åstrand CP, Juhl P, Johansen S, Hansen CD, Madsen B, Villesen IF, Leeming DJ, Thiele M, Hansen T, Karsdal M, Krag A. Torp N, et al. Among authors: hansen cd, hansen t. Liver Int. 2022 Jan;42(1):92-101. doi: 10.1111/liv.15120. Epub 2021 Dec 10. Liver Int. 2022. PMID: 34845832
Effects of a 6-month, low-carbohydrate diet on glycaemic control, body composition, and cardiovascular risk factors in patients with type 2 diabetes: An open-label randomized controlled trial.
Gram-Kampmann EM, Hansen CD, Hugger MB, Jensen JM, Brønd JC, Hermann AP, Krag A, Olsen MH, Beck-Nielsen H, Højlund K. Gram-Kampmann EM, et al. Among authors: hansen cd. Diabetes Obes Metab. 2022 Apr;24(4):693-703. doi: 10.1111/dom.14633. Epub 2022 Jan 25. Diabetes Obes Metab. 2022. PMID: 34984805 Clinical Trial.
Management of non-alcoholic fatty liver disease.
Hansen CD, Lindvig KP, Grønbæk H, Gluud LL, Thiele M, Krag A. Hansen CD, et al. Ugeskr Laeger. 2022 Oct 17;184(42):V04220239. Ugeskr Laeger. 2022. PMID: 36305262 Free article. Danish.
Effect of Calorie-Unrestricted Low-Carbohydrate, High-Fat Diet Versus High-Carbohydrate, Low-Fat Diet on Type 2 Diabetes and Nonalcoholic Fatty Liver Disease : A Randomized Controlled Trial.
Hansen CD, Gram-Kampmann EM, Hansen JK, Hugger MB, Madsen BS, Jensen JM, Olesen S, Torp N, Rasmussen DN, Kjærgaard M, Johansen S, Lindvig KP, Andersen P, Thorhauge KH, Brønd JC, Hermann P, Beck-Nielsen H, Detlefsen S, Hansen T, Højlund K, Thiele MS, Israelsen M, Krag A. Hansen CD, et al. Among authors: hansen jk, hansen t. Ann Intern Med. 2023 Jan;176(1):10-21. doi: 10.7326/M22-1787. Epub 2022 Dec 13. Ann Intern Med. 2023. PMID: 36508737 Clinical Trial.
Rifaximin-α for liver fibrosis in patients with alcohol-related liver disease (GALA-RIF): a randomised, double-blind, placebo-controlled, phase 2 trial.
Israelsen M, Madsen BS, Torp N, Johansen S, Hansen CD, Detlefsen S, Andersen P, Hansen JK, Lindvig KP, Rasmussen DN, Thorhauge KH, Kjærgaard M, Karsdal M, Hansen T, Arumugam M, Trebicka J, Thiele M, Krag A; GALAXY; MicrobLiver Consortia. Israelsen M, et al. Among authors: hansen cd, hansen jk, hansen t. Lancet Gastroenterol Hepatol. 2023 Jun;8(6):523-532. doi: 10.1016/S2468-1253(23)00010-9. Epub 2023 Mar 6. Lancet Gastroenterol Hepatol. 2023. PMID: 36893774 Free PMC article. Clinical Trial.
Using the ELF test, FIB-4 and NAFLD fibrosis score to screen the population for liver disease.
Kjaergaard M, Lindvig KP, Thorhauge KH, Andersen P, Hansen JK, Kastrup N, Jensen JM, Hansen CD, Johansen S, Israelsen M, Torp N, Trelle MB, Shan S, Detlefsen S, Antonsen S, Andersen JE, Graupera I, Ginés P, Thiele M, Krag A. Kjaergaard M, et al. Among authors: hansen jk, hansen cd. J Hepatol. 2023 Aug;79(2):277-286. doi: 10.1016/j.jhep.2023.04.002. Epub 2023 Apr 21. J Hepatol. 2023. PMID: 37088311 Free article. Clinical Trial.
Validation of scores of PRO-C3 to predict liver-related events in alcohol-related liver disease.
Johansen S, Israelsen M, Villesen IF, Torp N, Nielsen MJ, Kjaergaard M, Lindvig KP, Hansen CD, Andersen P, Rasmussen DN, Detlefsen S, Leeming DJ, Thiele M, Karsdal M, Krag A; GALAXY and MicrobLiver consortia. Johansen S, et al. Among authors: hansen cd. Liver Int. 2023 Jul;43(7):1486-1496. doi: 10.1111/liv.15595. Epub 2023 May 15. Liver Int. 2023. PMID: 37183542
77 results